Study: Souroujon 2023, International Journal of Dermatology

Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review

Citation

Souroujon AA, Guttman I, Levin N (2023). International Journal of Dermatology. PubMed id 37715361.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Vitiligo, spread, starting age and treatment options Tier B thin

    B Six studies of autologous (own-skin) cell transplants for stable segmental vitiligo; ancestry not given in the abstract (n=not stated)

    Systematic review.

    Cultured and non-cultured transplants each pigmented 80% or more of the treated area in the studies reviewed, with cultured cells doing better. The authors note the small amount of literature, and the cost and logistics that limit access.

    As recorded in this card: Souroujon AA, Guttman I, Levin N (2023), International Journal of Dermatology, [review]

    Note: Applies to stable segmental vitiligo only, not the common generalised type. These are the cell treatments sometimes described as stem cell treatment; our search found no randomised trial for generalised vitiligo that used the term stem cell and was opened.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.